Dup15q Syndrome is characterized by having an extra copy of a portion of chromosome 15 in the 11.2 – 13.1 region in combination with a number of symptoms that may include, hypotonia, epilepsy, cognitive delay, motor delays, autism, and similar facial features.
We empower individuals living with dup15q syndrome and other related rare diseases to reach their full potential by advancing breakthrough research and life-changing therapeutic treatments, supporting families affected by dup15q, and promoting advocacy.
We envision a world where families, clinicians, and advocates enable dup15q individuals to thrive.
Clinics and Trials
Families We Support
Number of Programs
Dollars to Research
Number of Clinics
Dup15q Alliance is proud to announce that we were selected as an Official Charity Partner for the 2022 TCS New York City Marathon, with 5 guaranteed entries. Dup15q Alliance will be among the 500 official charity partners providing thousands of runners the opportunity...
Congratulations to Julia Godinez, an undergraduate at UC Davis working in Dr. Janine LaSalle's Lab, on being the first recipient of the Lucas T. Ahn Family Scholarship! Dr. LaSalle's Lab studies the epigenetics of neurodevelopmental disorders including dup15q...
ATLANTA -- March 11, 2022 – Dup15q Alliance is proud to announce we have been selected as one of eight non-profit organizations that serve Atlantans for the Atlanta Journal-Constitution Peachtree Road Race Charity Partner Program. Dup15q Alliance will have 5...
This site is intended to provide basic educational information about chromosome 15q11.2-13.1 duplication syndrome. It is not intended to, nor does it, constitute medical or other advice. Readers are warned not to take any action with regard to medical treatment or otherwise based on the information on this website or bulletin board without first consulting a physician. Dup15q Alliance does not promote or recommend any treatment, therapy, institution, or health care plan.
The information contained in this site is intended for your general education and information only and not for use in pursuing any treatment or course of action. Ultimately, the course of action in treating a given patient must be individualized after a thorough discussion with the patient’s physician(s).